Compare ERIC & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ERIC | BNTX |
|---|---|---|
| Founded | 1876 | 2008 |
| Country | Sweden | Germany |
| Employees | 88826 | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.9B | 24.2B |
| IPO Year | N/A | 2019 |
| Metric | ERIC | BNTX |
|---|---|---|
| Price | $12.27 | $91.82 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 13 |
| Target Price | $11.00 | ★ $133.46 |
| AVG Volume (30 Days) | ★ 10.1M | 960.6K |
| Earning Date | 04-17-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.82% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.83 | $3.37 |
| P/E Ratio | $12.13 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.16 | $79.81 |
| 52 Week High | $13.77 | $124.00 |
| Indicator | ERIC | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 48.00 | 50.38 |
| Support Level | $10.97 | $90.67 |
| Resistance Level | $13.77 | $95.14 |
| Average True Range (ATR) | 0.34 | 2.71 |
| MACD | -0.15 | 0.32 |
| Stochastic Oscillator | 34.63 | 51.30 |
Ericsson is a networking equipment and software provider, primarily selling mobile networking equipment and services to wireless service providers. Ericsson operates in three segments: networks, cloud software and services, and enterprise. While large wireless carriers are its largest customers, Ericsson has expanded its offerings for large enterprises. These products and services include private 5G networking, contact centers as a service, and application performance interfaces. Ericsson aims to combine its 5G network expertise with cloud-native, as-a-service platforms offering a more comprehensive hardware and software package. Ericsson also monetizes its research and development investments by licensing patents to handset manufacturers.
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.